Pacific Biosciences of California, Inc. (PACB) was a big mover last session with its shares rising over 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend of the company, as the stock has lost over 9% in the past one-month time frame.
This biotechnology company has seen no estimate revision in the last 7 days. The Zacks Consensus Estimate hasn’t been in trend either. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Pacific Biosciences currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Some better-ranked Med-Drug stocks include Natus Medical Inc. (BABY), AngioDynamics Inc. (ANGO) and Cyberonics Inc. (CYBX). While BABY sports a Zacks Rank #1 (Strong Buy), ANGO and CYBX carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
PACIFIC BIOSCIENCES CALIFORNIA I (PACB): Free Stock Analysis Report
NATUS MEDICAL INC (BABY): Free Stock Analysis Report
ANGIODYNAMICS INC (ANGO): Free Stock Analysis Report
CYBERONICS INC (CYBX): Free Stock Analysis Report
Zacks Investment Research
- Finance Trading
- Personal Investing Ideas & Strategies
- Pacific Biosciences